• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LRRK2 I2020T 突变与 tau 病理学有关。

LRRK2 I2020T mutation is associated with tau pathology.

机构信息

Department of Neurology, Juntendo University, School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.

出版信息

Parkinsonism Relat Disord. 2012 Aug;18(7):819-23. doi: 10.1016/j.parkreldis.2012.03.024. Epub 2012 Apr 22.

DOI:10.1016/j.parkreldis.2012.03.024
PMID:22525366
Abstract

Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are the most common cause of autosomal-dominant familial Parkinson's disease (FPD). The variable pathological features of LRRK2-linked FPD include Lewy bodies, degeneration of anterior horn cells associated with axonal spheroids, neurofibrillary tangles (NFTs) and TAR DNA-binding protein of 43 kDa (TDP-43) positive inclusion bodies. Furthermore, abnormal hyperphosphorylation of microtubule associated protein tau, in part generated by catalysis of protein kinases, has been reported to be involved in progressive neurodegeneration in a number of diseases, including FPD. Thus, we examined six patients carrying the LRRK2 I2020T mutation, a pathogenic mutation associated with PARK8, and found abnormal tau phosphorylation depositions in the brainstem. Additionally, we found LRRK2 I2020T enhanced tau phosphorylation in cultured cells co-expressing LRRK2-I2020T and 3 or 4-repeated tau. This is the first report describing the relationship between hyperphosphorylation of tau and LRRK2 I2020T.

摘要

LRRK2 基因突变是常染色体显性家族性帕金森病(FPD)最常见的原因。LRRK2 相关 FPD 的可变病理特征包括路易体、与轴突球体相关的前角细胞变性、神经原纤维缠结(NFT)和 TAR DNA 结合蛋白 43 kDa(TDP-43)阳性包涵体。此外,微管相关蛋白 tau 的异常过度磷酸化,部分由蛋白激酶催化产生,据报道与包括 FPD 在内的多种疾病的进行性神经退行性变有关。因此,我们检查了 6 名携带 LRRK2 I2020T 突变的患者,该突变与 PARK8 相关,发现脑干中有异常 tau 磷酸化沉积。此外,我们发现共表达 LRRK2-I2020T 和 3 或 4 重复 tau 的培养细胞中 LRRK2 I2020T 增强了 tau 的磷酸化。这是首次描述 tau 的过度磷酸化与 LRRK2 I2020T 之间的关系。

相似文献

1
LRRK2 I2020T mutation is associated with tau pathology.LRRK2 I2020T 突变与 tau 病理学有关。
Parkinsonism Relat Disord. 2012 Aug;18(7):819-23. doi: 10.1016/j.parkreldis.2012.03.024. Epub 2012 Apr 22.
2
I2020T mutant LRRK2 iPSC-derived neurons in the Sagamihara family exhibit increased Tau phosphorylation through the AKT/GSK-3β signaling pathway.相模原家族中 I2020T 突变型 LRRK2 诱导多能干细胞衍生的神经元通过 AKT/GSK-3β 信号通路使 Tau 磷酸化增加。
Hum Mol Genet. 2015 Sep 1;24(17):4879-900. doi: 10.1093/hmg/ddv212. Epub 2015 Jun 8.
3
Dominant-negative effects of LRRK2 heterodimers: a possible mechanism of neurodegeneration in Parkinson's disease caused by LRRK2 I2020T mutation.LRRK2 异源二聚体的显性负效应:LRRK2 I2020T 突变导致帕金森病神经退行性变的可能机制。
Biochem Biophys Res Commun. 2013 Jan 11;430(2):560-6. doi: 10.1016/j.bbrc.2012.11.113. Epub 2012 Dec 7.
4
Neuropathology of Parkinson's disease associated with the LRRK2 Ile1371Val mutation.与LRRK2基因Ile1371Val突变相关的帕金森病神经病理学
Mov Disord. 2007 Jan 15;22(2):275-8. doi: 10.1002/mds.21281.
5
[Clinical molecular genetics for PARK8 (LRRK2)].PARK8(LRRK2)的临床分子遗传学
Brain Nerve. 2007 Aug;59(8):839-50.
6
Physiologically relevant factors influence tau phosphorylation by leucine-rich repeat kinase 2.生理相关因素影响富含亮氨酸重复激酶2介导的tau蛋白磷酸化。
J Neurosci Res. 2015 Oct;93(10):1567-80. doi: 10.1002/jnr.23614. Epub 2015 Jun 30.
7
Differential effects of familial parkinson mutations in LRRK2 revealed by a systematic analysis of autophosphorylation.LRRK2 自身磷酸化的系统分析揭示家族性帕金森病突变的差异效应。
Biochemistry. 2013 Sep 3;52(35):6052-62. doi: 10.1021/bi400596m. Epub 2013 Aug 23.
8
TDP-43 pathology in a patient carrying G2019S LRRK2 mutation and a novel p.Q124E MAPT.携带 G2019S LRRK2 突变和新的 p.Q124E MAPT 的患者的 TDP-43 病理学。
Neurobiol Aging. 2013 Dec;34(12):2889.e5-9. doi: 10.1016/j.neurobiolaging.2013.04.011. Epub 2013 May 9.
9
Lack of exacerbation of neurodegeneration in a double transgenic mouse model of mutant LRRK2 and tau.突变型LRRK2和tau双转基因小鼠模型中神经退行性变未加重
Hum Mol Genet. 2015 Jun 15;24(12):3545-56. doi: 10.1093/hmg/ddv105. Epub 2015 Mar 24.
10
Leucine-rich repeat kinase 2 regulates tau phosphorylation through direct activation of glycogen synthase kinase-3β.富含亮氨酸重复激酶 2 通过直接激活糖原合成酶激酶 3β 来调节 tau 磷酸化。
FEBS J. 2014 Jan;281(1):3-13. doi: 10.1111/febs.12579. Epub 2013 Nov 28.

引用本文的文献

1
Accumulation of LRRK2-associated phospho-Rab12 degenerative lysosomes in tauopathies.富含亮氨酸重复激酶2相关磷酸化Rab12的退行性溶酶体在tau蛋白病中的积累。
bioRxiv. 2025 Jun 9:2025.06.06.658328. doi: 10.1101/2025.06.06.658328.
2
Dopamine and cortical neurons with different Parkinsonian mutations show variation in lysosomal and mitochondrial dysfunction.多巴胺与携带不同帕金森氏症突变的皮层神经元在溶酶体和线粒体功能障碍方面存在差异。
NPJ Parkinsons Dis. 2025 Jun 20;11(1):177. doi: 10.1038/s41531-025-01048-2.
3
Neuropathological examination of 12 cases of familial Parkinson's disease with LRRK2 I2020T mutation including tau and TDP-43 pathology.
对12例携带LRRK2 I2020T突变的家族性帕金森病患者进行神经病理学检查,包括tau蛋白和TDP - 43病理学检查。
J Neurol. 2025 Jun 9;272(7):450. doi: 10.1007/s00415-025-13148-3.
4
Widespread distribution of α-synuclein oligomers in LRRK2-related Parkinson's disease.α-突触核蛋白寡聚体在与富亮氨酸重复激酶2(LRRK2)相关的帕金森病中的广泛分布。
Acta Neuropathol. 2025 May 2;149(1):42. doi: 10.1007/s00401-025-02872-9.
5
Abundant non-inclusion α-synuclein pathology in Lewy body-negative LRRK2-mutant cases.路易体阴性的LRRK2突变病例中存在大量非包涵体型α-突触核蛋白病理改变。
Acta Neuropathol. 2025 May 2;149(1):41. doi: 10.1007/s00401-025-02871-w.
6
The homozygous LRRK2.p.N1437D point mutation mouse is a novel model of parkinsonism.纯合型LRRK2.p.N1437D点突变小鼠是帕金森病的一种新型模型。
NPJ Parkinsons Dis. 2025 Mar 28;11(1):61. doi: 10.1038/s41531-025-00905-4.
7
A personalised and comprehensive approach is required to suppress or replenish SNCA for Parkinson's disease.需要一种个性化且全面的方法来抑制或补充帕金森病中的α-突触核蛋白(SNCA)。
NPJ Parkinsons Dis. 2025 Mar 4;11(1):42. doi: 10.1038/s41531-025-00887-3.
8
Widespread Distribution of α-Synuclein Oligomers in -related Parkinson's Disease.α-突触核蛋白寡聚体在帕金森病中的广泛分布
bioRxiv. 2024 Dec 20:2024.12.18.629265. doi: 10.1101/2024.12.18.629265.
9
The LRRK2 kinase substrates RAB8a and RAB10 contribute complementary but distinct disease-relevant phenotypes in human neurons.富含亮氨酸重复激酶2(LRRK2)的激酶底物RAB8a和RAB10在人类神经元中呈现出互补但不同的疾病相关表型。
Stem Cell Reports. 2024 Feb 13;19(2):163-173. doi: 10.1016/j.stemcr.2024.01.001. Epub 2024 Feb 1.
10
Upregulation of LRRK2 following traumatic brain injury does not directly phosphorylate Thr tau.创伤性脑损伤后LRRK2的上调不会直接使苏氨酸tau蛋白磷酸化。
Front Cell Neurosci. 2023 Nov 8;17:1272899. doi: 10.3389/fncel.2023.1272899. eCollection 2023.